retatrutide trial results news today

retatrutide trial results news today 🚨 Big dropped — and here's why it actually matters. Yes, the “reta rats” have been talking about this molecule for years. But today's TRIUMPH-1 Phase 3 aren't Lilly's triple agonist, retatrutide, delivered

Name: retatrutide trial results news today 🚨 Big dropped — and here's why it actually matters. Yes, the “reta rats” have been talking about this molecule for years. But today's TRIUMPH-1 Phase 3 aren't Lilly's triple agonist, retatrutide, delivered
Brand: begonvillage.com
SKU: 915373952
Price: 27.09 USD
Availability: InStock
Rating: 4.2061 (18 reviews)

SKU: 915373952

4.2

EUR27.09 EUR55.09

Pay in 4 interest-free payments of $6.77 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 30 - Oct 5

Description

The combined primary endpoint of death from cardiovascular disease, nonfatal myocardial infarction, or nonfatal stroke occurred in 569 (6.5%) of patients in the semaglutide group versus 701 (8.0%) of patients in the placebo group, yielding a significant hazard ratio of 0.8 for a 20% relative risk reduction